Search - tctmd.com

Displaying 161 - 180 of 228

Sort: Relevancy | Date

Presentation TCT 2015

Pathophysiology and Natural History

Presenter: John S. Douglas Jr, Sherif F. Nagueh, Mark V. Sherrid

October 15, 2015

News Conference News TCT 2015

Valve-in-Valve TAVR Benefits Patients with Failing Surgical Bioprosthetic Valves

Todd Neale

October 15, 2015

Presentation TCT 2015

Initial Clinical Results of Transcatheter Technique for LV Volume Reduction Treatment of Ischemic Cardiomyopathy

Presenter: Andrea Abizaid, Daniel Burkhoff, Salvatore Brugaletta

October 14, 2015

Presentation TCT 2015

ALSTER-CERA: Evaluation of NOGA-Guided Intramyocardial Injection of a Long-Acting Erythropoietin Analogue in Patients With Ischemic Cardiomyopathy

Presenter: David P. Faxon, David O. Williams, Martin W Bergmann

October 13, 2015

Presentation TCT 2015

Severe Septal Bulge (± Hypertrophic Cardiomyopathy) and TAVR: Thoughtful Commentary on the Case

Presenter: D. Craig Miller, Alec S. Vahanian, Jan Kovac

October 12, 2015

Presentation TCT 2015

Severe Septal Bulge (± Hypertrophic Cardiomyopathy) and TAVR: Case Presentation

Presenter: D. Craig Miller, Alec S. Vahanian, Mayra Guerrero

October 12, 2015

News Conference News TCT 2015

V-Wave Device Offers Functional, Hemodynamic Gains for Patients With Systolic HF

October 11, 2015

News Conference News TCT 2015

Global TAVR Market Poised to Exceed DES Market by 2025

October 11, 2015

Presentation TCT 2014

TCT 64: Coil Embolization for Septal Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy: Long-term Results

Presenter: Igor F. Palacios, Augusto D. Pichard, Kishore J. Harjai, Israel Guerrero Mantilla, MD

September 16, 2014

Presentation TCT 2014

TCT 63: Objective Assessment of Intracardiac Conduction to Guide Permanent Pacemaker Implantation Following Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy

Presenter: Igor F. Palacios, Augusto D. Pichard, Kishore J. Harjai, Malek Al-Hawwas, MD

September 16, 2014

Presentation TCT 2014

Interventional Perspective: Not Surgery of Course!

Presenter: Carey D. Kimmelstiel

September 16, 2014

Presentation TCT 2014

Surgeon's Perspective on HOCM surgery

Presenter: John D. Puskas

September 16, 2014

Presentation TCT 2014

Long-term Outcomes Following Alcohol Septal Ablation: Is the Procedure Durable?

Presenter: Srihari S. Naidu, Paul Sorajja, Sherif F. Nagueh

September 16, 2014

Presentation TCT 2014

Complications of Alcohol Septal Ablation

Presenter: Srihari S. Naidu, Paul Sorajja, Sherif F. Nagueh

September 16, 2014

Presentation TCT 2014

Patient Management Post Ablation

Presenter: Srihari S. Naidu, Paul Sorajja, Sherif F. Nagueh

September 16, 2014

Presentation TCT 2014

HCM Ablation Step-by-Step and Avoiding Potential Pitfalls

Presenter: Srihari S. Naidu, Paul Sorajja, Sherif F. Nagueh, Valerian Fernandes

September 16, 2014

Presentation TCT 2014

Case Selection and Use of Myocardial Contrast Echocardiography During Ablation

Presenter: Srihari S. Naidu, Paul Sorajja, Sherif F. Nagueh

September 16, 2014

Presentation TCT 2014

When to Consider Septal Reduction Therapy

Presenter: John S. Douglas Jr, Sherif F. Nagueh, Howard C. Herrmann

September 16, 2014

Presentation TCT 2014

Sudden Cardiac Death and Atrial Fibrillation in HCM

Presenter: John S. Douglas Jr, Sherif F. Nagueh, Howard C. Herrmann, Kishore J. Harjai

September 16, 2014

Presentation TCT 2014

Hemodynamics of Dynamic Obstruction

Presenter: John S. Douglas Jr, Sherif F. Nagueh, Howard C. Herrmann, James B. Hermiller Jr

September 16, 2014

Advertisement

Pathophysiology and Natural History

Valve-in-Valve TAVR Benefits Patients with Failing Surgical Bioprosthetic Valves

Initial Clinical Results of Transcatheter Technique for LV Volume Reduction Treatment of Ischemic Cardiomyopathy

ALSTER-CERA: Evaluation of NOGA-Guided Intramyocardial Injection of a Long-Acting Erythropoietin Analogue in Patients With Ischemic Cardiomyopathy

Severe Septal Bulge (± Hypertrophic Cardiomyopathy) and TAVR: Thoughtful Commentary on the Case

Severe Septal Bulge (± Hypertrophic Cardiomyopathy) and TAVR: Case Presentation

V-Wave Device Offers Functional, Hemodynamic Gains for Patients With Systolic HF

Global TAVR Market Poised to Exceed DES Market by 2025

TCT 64: Coil Embolization for Septal Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy: Long-term Results

TCT 63: Objective Assessment of Intracardiac Conduction to Guide Permanent Pacemaker Implantation Following Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy

Interventional Perspective: Not Surgery of Course!

Surgeon's Perspective on HOCM surgery

Long-term Outcomes Following Alcohol Septal Ablation: Is the Procedure Durable?

Complications of Alcohol Septal Ablation

Patient Management Post Ablation

HCM Ablation Step-by-Step and Avoiding Potential Pitfalls

Case Selection and Use of Myocardial Contrast Echocardiography During Ablation

When to Consider Septal Reduction Therapy

Sudden Cardiac Death and Atrial Fibrillation in HCM

Hemodynamics of Dynamic Obstruction

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content